Ionis Pharmaceuticals (IONS) is up 31.2%, or $13.28 to $55.92.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IONS:
- Ionis Pharmaceuticals’ Olezarsen Triumphs in Phase 3 Trials, Analyst Raises Price Target
- Ionis Pharmaceuticals rises 26.5%
- Ionis Pharmaceuticals price target raised to $96 from $83 at Jefferies
- Ionis Pharmaceuticals price target raised to $95 from $70 at H.C. Wainwright
- Ionis Pharmaceuticals’ Olezarsen Shows Promising Phase III Results in Reducing Triglycerides and Pancreatitis Risk